These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 30529078)

  • 1. Membrane interaction of off-pathway prion oligomers and lipid-induced on-pathway intermediates during prion conversion: A clue for neurotoxicity.
    Combet S; Cousin F; Rezaei H; Noinville S
    Biochim Biophys Acta Biomembr; 2019 Feb; 1861(2):514-523. PubMed ID: 30529078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vesicle permeabilization by purified soluble oligomers of prion protein: a comparative study of the interaction of oligomers and monomers with lipid membranes.
    Chich JF; Chapuis C; Henry C; Vidic J; Rezaei H; Noinville S
    J Mol Biol; 2010 Apr; 397(4):1017-30. PubMed ID: 20156446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conformation-dependent membrane permeabilization by neurotoxic PrP oligomers: The role of the H2H3 oligomerization domain.
    Huin C; Cronier S; Guégan P; Béringue V; Rezaei H; Noinville S
    Arch Biochem Biophys; 2020 Oct; 692():108517. PubMed ID: 32738196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prion protein oligomer and its neurotoxicity.
    Huang P; Lian F; Wen Y; Guo C; Lin D
    Acta Biochim Biophys Sin (Shanghai); 2013 Jun; 45(6):442-51. PubMed ID: 23557632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phospholipids influence the aggregation of recombinant ovine prions. From rapid extensive aggregation to amyloidogenic conversion.
    Tsiroulnikov K; Shchutskaya Y; Muronetz V; Chobert JM; Haertlé T
    Biochim Biophys Acta; 2009 Mar; 1794(3):506-11. PubMed ID: 19124088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteolysis of prion protein by cathepsin S generates a soluble beta-structured intermediate oligomeric form, with potential implications for neurotoxic mechanisms.
    Polyakova O; Dear D; Stern I; Martin S; Hirst E; Bawumia S; Nash A; Dodson G; Bronstein I; Bayley PM
    Eur Biophys J; 2009 Feb; 38(2):209-18. PubMed ID: 18813919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthetic lipid vesicles recruit native-like aggregates and affect the aggregation process of the prion Ure2p: insights on vesicle permeabilization and charge selectivity.
    Pieri L; Bucciantini M; Guasti P; Savistchenko J; Melki R; Stefani M
    Biophys J; 2009 Apr; 96(8):3319-30. PubMed ID: 19383475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mechanism of membrane disruption by cytotoxic amyloid oligomers formed by prion protein(106-126) is dependent on bilayer composition.
    Walsh P; Vanderlee G; Yau J; Campeau J; Sim VL; Yip CM; Sharpe S
    J Biol Chem; 2014 Apr; 289(15):10419-10430. PubMed ID: 24554723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amyloid formation by recombinant full-length prion proteins in phospholipid bicelle solutions.
    Lührs T; Zahn R; Wüthrich K
    J Mol Biol; 2006 Mar; 357(3):833-41. PubMed ID: 16466741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conformational Switching and Nanoscale Assembly of Human Prion Protein into Polymorphic Amyloids via Structurally Labile Oligomers.
    Dalal V; Arya S; Bhattacharya M; Mukhopadhyay S
    Biochemistry; 2015 Dec; 54(51):7505-13. PubMed ID: 26645611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein misfolding cyclic amplification induces the conversion of recombinant prion protein to PrP oligomers causing neuronal apoptosis.
    Yuan Z; Yang L; Chen B; Zhu T; Hassan MF; Yin X; Zhou X; Zhao D
    J Neurochem; 2015 Jun; 133(5):722-9. PubMed ID: 25810062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble Prion Protein Binds Isolated Low Molecular Weight Amyloid-β Oligomers Causing Cytotoxicity Inhibition.
    Williams TL; Choi JK; Surewicz K; Surewicz WK
    ACS Chem Neurosci; 2015 Dec; 6(12):1972-80. PubMed ID: 26466138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A neurotoxic and gliotrophic fragment of the prion protein increases plasma membrane microviscosity.
    Salmona M; Forloni G; Diomede L; Algeri M; De Gioia L; Angeretti N; Giaccone G; Tagliavini F; Bugiani O
    Neurobiol Dis; 1997; 4(1):47-57. PubMed ID: 9258911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of prion protein to lipid membranes and implications for prion conversion.
    Sanghera N; Pinheiro TJ
    J Mol Biol; 2002 Feb; 315(5):1241-56. PubMed ID: 11827491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prion protein-mediated toxicity of amyloid-β oligomers requires lipid rafts and the transmembrane LRP1.
    Rushworth JV; Griffiths HH; Watt NT; Hooper NM
    J Biol Chem; 2013 Mar; 288(13):8935-51. PubMed ID: 23386614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biosensing of lipid-prion interactions: insights on charge effect, Cu(II)-ions binding and prion oligomerization.
    Steunou S; Chich JF; Rezaei H; Vidic J
    Biosens Bioelectron; 2010 Dec; 26(4):1399-406. PubMed ID: 20692152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Unexposed Secrets of Prion Protein Oligomers.
    Wang G; Wang M; Li C
    J Mol Neurosci; 2015 Aug; 56(4):932-937. PubMed ID: 25823438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of rafts in the fibrillization and aggregation of prions.
    Pinheiro TJ
    Chem Phys Lipids; 2006 Jun; 141(1-2):66-71. PubMed ID: 16647049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Membrane interactions and conformational preferences of human and avian prion N-terminal tandem repeats: the role of copper(II) ions, pH, and membrane mimicking environments.
    Di Natale G; Pappalardo G; Milardi D; Sciacca MF; Attanasio F; La Mendola D; Rizzarelli E
    J Phys Chem B; 2010 Nov; 114(43):13830-8. PubMed ID: 20936829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutron reflectometry studies define prion protein N-terminal peptide membrane binding.
    Le Brun AP; Haigh CL; Drew SC; James M; Boland MP; Collins SJ
    Biophys J; 2014 Nov; 107(10):2313-24. PubMed ID: 25418300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.